Treatment of Chronic Pain in Dogs

Hielm‐Björkman, Anna

doi:10.1002/9781118999196.ch23

Cited by 2 publications

(1 citation statement)

References 211 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The following three parts were then included in every round of data collection: (i) Of a total of 19 pain related descriptive scale (0–4) questions on attitude, behaviour, and locomotion, 11 questions formed the owner-assessed HCPI, as described previously [44-47]. (This index now has a new English translation that is closer to the Finnish original; the HCPI-E2, but the validated original remains the same [47,48]). (ii) Two 10-cm VAS: one for lameness and the other for quality of life (QOL).…”

Section: Methodsmentioning

confidence: 99%

An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA

et al. 2012

Self Cite

View full text Add to dashboard Cite

BackgroundAn un-commissioned randomized, double-blinded, placebo controlled clinical study was planned using a deep sea fish oil product for pets. Seventy-seven client-owned dogs with osteoarthritis were randomly assigned to supplement the food with either the fish oil product or corn (=placebo) oil. Our main outcome variables were force platform variables peak vertical force (PVF) and impulse, the validated Helsinki Chronic Pain Index (HCPI) and the use of rescue NSAIDs. Secondary outcome variables were a locomotion visual analog scale (VAS), a Quality of life VAS, a comparative questionnaire, a veterinary assessment, owners’ final assessment of outcome and guessing the product given.ResultsWhen comparing the two test groups at the end of the trial (16 weeks) there was no significant difference in any of the main outcome variables but owners of dogs that had taken fish oil were significantly happier with the treatment at the end visit and did significantly better at guessing what group their dogs had been in, compared to the placebo group. When comparing variables within the fish oil group as change from baseline to trial end, there were significant positive changes in PVF, HCPI, NSAID use, Quality of life VAS, as well as in all three scores in the comparative questionnaire (locomotion, every-day situations, and skin & coat). There were similar positive trends in force platform impulse and in the veterinary assessment variables, although they did not reach significance. Within the placebo group there were significant positive changes only in the HCPI and a significant deterioration according to veterinary assessment.ConclusionsWhen compared to placebo, there was not a major statistically significant benefit in using deep sea fish oil as a pain reliever in our study population of dogs suffering from osteoarthritis. However, the fish oil treated patients improved significantly in many of the variables, when comparing baseline values to the study-end values within the group, indicating a true but small relief in symptoms. Deep sea fish oil supplementation could be considered a part of the multimodal pain relieving approach currently recommended for dogs suffering from OA, especially for individuals that do not tolerate anti-inflammatory drugs.

show abstract

Section: Methodsmentioning

confidence: 99%

An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA

et al. 2012

Self Cite

View full text Add to dashboard Cite

show abstract

Multimodale Therapie der kaninen Osteoarthritis – aktueller Stand und neue Optionen

Diehm¹,

Tünsmeyer²

2018

Tierarztl Prax Ausg K

View full text Add to dashboard Cite

ZusammenfassungDie Osteoarthritis des Hundes ist eine sehr oft vorkommende Erkrankung und die häufigste Ursache für chronische Schmerzen beim Hund. Durch eine progressive Degeneration des Gelenkknorpels sowie weiterer Gelenkstrukturen kommt es zur konsekutiven Entwicklung osteophytärer Zubildungen sowie Entzündungsreaktionen und Schmerz. Eine vollständige Heilung ist nicht möglich. Ein multimodales Behandlungsschema zielt darauf ab, das Fortschreiten der Erkrankung zu verlangsamen und die Lebensqualität des Hundes zu steigern. Der Artikel gibt einen Überblick zu den verschiedenen Therapieoptionen. Derzeit wird eine Vielzahl von Analgetika zur pharmazeutischen Therapie der Osteoarthritis eingesetzt. Für eine effektive Behandlung dieser Erkrankung ist eine antientzündliche Wirkung sehr wichtig, doch geht insbesondere die langfristige Anwendung antiinflammatorisch wirksamer Medikamente mit erheblichen Nebenwirkungen einher. Durch eine für den Hund neu zugelassene Wirkstoffklasse, die sogenannten Piprante, besteht die Hoffnung auf ein verbessertes Sicherheitsprofil bei der medikamentösen Therapie chronisch entzündlicher Gelenkerkrankungen.

show abstract

Treatment of Chronic Pain in Dogs

Cited by 2 publications

References 211 publications

An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA

An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA

Multimodale Therapie der kaninen Osteoarthritis – aktueller Stand und neue Optionen

Contact Info

Product

Resources

About